Literature DB >> 26989643

The progress of angiogenic factors in the development of leukemias.

Yang Han1, Xidi Wang2, Bingping Wang3, Guosheng Jiang4.   

Abstract

Angiogenic factors have been demonstrated to play important roles in modulating angiogenesis of solid tumors. Recently, accumulating studies extensively indicated that some angiogenic factors widely exist in malignant cells of hematologic malignancy, which regulated the expression of a number of genes that were involved in abnormal proliferation, differentiation and apoptosis of these cells. With deep research of angiogenic factors, its expression, function and regulatory mechanism were gradually elucidated, and some of them were related to the development and prognosis of leukemia, or provide more possible strategies for treatment of patients with leukemia. Herein, we summarize the progress in study of some important angiogenic factors and hematological malignancies.

Entities:  

Keywords:  Angiogenesis; angiogenic factors; leukemia

Year:  2016        PMID: 26989643      PMCID: PMC4761589          DOI: 10.5582/irdr.2015.01048

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  110 in total

Review 1.  Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis.

Authors:  Y Dor; R Porat; E Keshet
Journal:  Am J Physiol Cell Physiol       Date:  2001-06       Impact factor: 4.249

2.  Restoration of natural killer cell cytotoxicity by VEGFR-3 inhibition in myelogenous leukemia.

Authors:  Ji Yoon Lee; Sohye Park; Woo-Sung Min; Hee-Je Kim
Journal:  Cancer Lett       Date:  2014-08-23       Impact factor: 8.679

3.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

4.  Gene expression changes in a tumor xenograft by a pyrrole-imidazole polyamide.

Authors:  Jevgenij A Raskatov; Nicholas G Nickols; Amanda E Hargrove; Georgi K Marinov; Barbara Wold; Peter B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

5.  Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth.

Authors:  D Gospodarowicz
Journal:  Nature       Date:  1974-05-10       Impact factor: 49.962

6.  HIF-1α downregulates miR-17/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation.

Authors:  M He; Q-Y Wang; Q-Q Yin; J Tang; Y Lu; C-X Zhou; C-W Duan; D-L Hong; T Tanaka; G-Q Chen; Q Zhao
Journal:  Cell Death Differ       Date:  2012-10-12       Impact factor: 15.828

7.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

8.  Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.

Authors:  Håkon Reikvam; Kimberley J Hatfield; Anne M Oyan; Karl H Kalland; Astrid O Kittang; Oystein Bruserud
Journal:  Eur J Haematol       Date:  2009-11-17       Impact factor: 2.997

9.  VEGF-D is expressed in activated lymphoid cells and in tumors of hematopoietic and lymphoid tissues.

Authors:  Monia Bardelli; Eleonora Leucci; Karin Schürfeld; Cristiana Bellan; Giovanni Passiatore; Marina Rocchigiani; Sabrina Bartolommei; Maurizio Orlandini; Jennifer Zagursky; Stefano Lazzi; Giulia De Falco; Piero Tosi; Salvatore Oliviero; Lorenzo Leoncini
Journal:  Leuk Lymphoma       Date:  2007-10

10.  Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha.

Authors:  Y Huang; K-M Du; Z-H Xue; H Yan; D Li; W Liu; Z Chen; Q Zhao; J-H Tong; Y-S Zhu; G-Q Chen
Journal:  Leukemia       Date:  2003-11       Impact factor: 11.528

View more
  7 in total

Review 1.  Post-transcriptional regulation of cytokine and growth factor signaling in cancer.

Authors:  Irina Vlasova-St Louis; Paul R Bohjanen
Journal:  Cytokine Growth Factor Rev       Date:  2016-12-02       Impact factor: 7.638

Review 2.  Bone Marrow Blood Vessels: Normal and Neoplastic Niche.

Authors:  Saeid Shahrabi; Hadi Rezaeeyan; Ahmad Ahmadzadeh; Mohammad Shahjahani; Najmaldin Saki
Journal:  Oncol Rev       Date:  2016-11-24

Review 3.  Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?

Authors:  Ebru Aydin; Sebastian Faehling; Mariam Saleh; Laura Llaó Cid; Martina Seiffert; Philipp M Roessner
Journal:  Front Immunol       Date:  2021-01-20       Impact factor: 7.561

Review 4.  Targeting PI3K/Akt signal transduction for cancer therapy.

Authors:  Yan He; Miao Miao Sun; Guo Geng Zhang; Jing Yang; Kui Sheng Chen; Wen Wen Xu; Bin Li
Journal:  Signal Transduct Target Ther       Date:  2021-12-16

5.  Investigating the expression pattern of the angiopoietin-Tie system in ALL and its correlation with baseline characteristics.

Authors:  Saeed Zaka Khosravi; Samira Molaei Ramshe; Mehdi Allahbakhshian Farsani; Saeed Solali; Mohammadreza Moonesi; Majid Farshdousti Hagh
Journal:  Blood Res       Date:  2021-06-30

Review 6.  Acute Myeloid Leukemia and the Bone Marrow Niche-Take a Closer Look.

Authors:  Lena Behrmann; Jasmin Wellbrock; Walter Fiedler
Journal:  Front Oncol       Date:  2018-10-12       Impact factor: 6.244

Review 7.  Modulating barriers of tumor microenvironment through nanocarrier systems for improved cancer immunotherapy: a review of current status and future perspective.

Authors:  Huanrong Lan; Wei Zhang; Ketao Jin; Yuyao Liu; Zhen Wang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.